The PhD in Pharmaceutical Sciences (PSC) program is divided into three programs in Chemical and Biology Discovery, Translational Therapeutics, and Pharmacometrics.

Students select a mentor from one program under which to pursue their doctoral research, though faculty often work together as part of the program's highly collaborative environment. Explore the links below to learn more about each faculty member.

Chemical and Biological Discovery Program:

Faculty in this program are engaged in research at the interface of biology, chemistry, and computational sciences to explore biological mechanisms in the development of novel new technologies and therapeutics.

Andrew Coop, PhD Amanda Oglesby-Sherrouse, PhD
Steven Fletcher, PhD C.S. Raman, PhD
David Goodlett, PhD Paul Shapiro, PhD
Jace Jones, PhD Jana Shen, PhD
Lisa Jones, PhD Angela Wilks, PhD
Maureen Kane, PhD Patrick Wintrode, PhD
Alexander MacKerell, PhD Fengtian Xue, PhD
Sarah Michel, PhD  

Translational Therapeutics Program:

Faculty in this program are engaged in optimizing drug metabolism and pharmacokinetics and therapeutic efficacy of drugs through a combined strategy that integrates experimental and translational therapeutic approaches.

Richard Dalby, PhD Yan Shu, PhD
Natalie D. Eddington, PhD, FCP, FAAPS Audra Stinchcomb, PhD
Hazem Hassan, PhD Peter Swaan, PhD
Stephen Hoag, PhD Hongbing Wang, PhD
Edward Moreton, PhD Jia Bei Wang, PhD
James Polli, PhD Bruce Yu, PhD
Gerald Rosen, PhD  

Pharmacometrics:

Faculty in this program are engaged in helping students obtain the skills and knowledge necessary to plan, perform, and interpret pharmacometric analyses with the goal of influencing key drug development, regulatory, and therapeutic decisions.

Joga Gobburu, PhD
Mathangi Gopalakrishnan, MS, PhD
Vijay Ivaturi, PhD